gettyimages 2287299632

Moderna stock more than doubles after melanoma vaccine trial shows “landmark moment”

Drugmaker Moderna’s stock more than doubled on Wednesday morning after the company announced a successful experimental mRNA vaccine to treat melanoma, the deadly skin cancer from which more than 8,500 people are expected to die this year. Moderna and Merck, its drug development partner, said the novel treatment prevented melanoma from returning or spreading in a…

Read More